Eli Lilly pauses trial of antibody drug over safety concern
Eli Lilly pauses trial of antibody drug over safety concern
October 13, 2020
U.S. drugmaker Eli Lilly said that the government-sponsored clinical trial of its COVID-19 antibody treatment similar to one taken by President Donald Trump has been paused because of a safety concern.
Post A Comment:
0 comments:
Leave a comment. Thanks!